Skip to main content

NGEN · Nervgen Pharma Corp. · Analyst Estimates

Track NGEN — free
$2.19 +0.03 (+1.16%) At close · Sep 11
Market Cap
$234.94M
Shares
107.52M

Analyst Estimates

Compare analyst forecasts for Nervgen Pharma Corp. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1751912 CUSIP 64082X203 13F (30d) 21 filings 21 filers Visit website